Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lumos Diagnostics Holdings Ltd. ( (AU:LDX) ) has issued an update.
Lumos Diagnostics has received a cash refund of A$215,485 under the Australian Government’s Research and Development Tax Incentive for its FY2024 efforts. This refund supports Lumos’ ongoing R&D in enhancing its diagnostic technology platform, which is crucial for securing partnerships and advancing point-of-care technologies.
More about Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics specializes in rapid point-of-care diagnostic test technology, offering customized assay development and manufacturing services. The company develops, manufactures, and commercializes novel Lumos-branded point-of-care tests targeting infectious and inflammatory diseases.
Average Trading Volume: 1,248,769
Technical Sentiment Signal: Sell
Current Market Cap: A$21.71M
For detailed information about LDX stock, go to TipRanks’ Stock Analysis page.